E-ISSN 2577-5669
 
2023, Vol: 14, Issue: 2
14/2Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Cover Letter
Title Page

Research Article 


The Incidence of Adverse Effects of Monoclonal Antibodies in Breast and Gynec Cancer Patients

AMIRHOSSEIN SETAYESH, GOPINATH ELUMALAI.

Abstract
Objectives: This study focuses on the severity of the adverse effects induced by monoclonal antibodies in Indian population. This study is performed in a multispecialty hospital and adverse effects were monitored in the study population. Therefore, the main objective of the study was active surveillance of adverse effects induced by monoclonal antibodies.
Methodology: A cohort study was conducted in 120 patients with breast and gynaecological cancer for a period of 6 months in a multispecialty hospital.
Result: Among 120 patients Breast cancer was the most prevalent followed by cervical cancer. Adverse effects were seen in all age groups, most adverse effects were reported with Trastuzumab (37.50%) and Bevacizumab (26.78%). Monoclonal antibodies were well tolerated by the patients with minimum adverse effects which are manageable with supportive therapy, the most prevalent adverse effect was anaemia.
Conclusion: By assessing Adverse effects using Naranjo scale, most of them were found to be possible (32%) and probable (67%). In WHO scale, the most of the adverse effects were also follow under category of possible (38.14%) and probable (61.20%). Of all adverse effects no severe adverse effects were seen in the patients, i.e. monoclonal antibodies were well tolerated by the patients.

Key words: Naranjo Scale, WHO Scale, Monoclonal Antibodies, Breast cancer, Gynaecological cancers


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by AMIRHOSSEIN SETAYESH
Articles by GOPINATH ELUMALAI
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

AMIRHOSSEIN SETAYESH, GOPINATH ELUMALAI. The Incidence of Adverse Effects of Monoclonal Antibodies in Breast and Gynec Cancer Patients. J Complement Med Res. 2021; 12(4): 148-163. doi:10.5455/jcmr.2021.12.04.24

Web Style

AMIRHOSSEIN SETAYESH, GOPINATH ELUMALAI. The Incidence of Adverse Effects of Monoclonal Antibodies in Breast and Gynec Cancer Patients. https://www.jocmr.com/?mno=140638 [Access: May 26, 2023]. doi:10.5455/jcmr.2021.12.04.24

AMA (American Medical Association) Style

AMIRHOSSEIN SETAYESH, GOPINATH ELUMALAI. The Incidence of Adverse Effects of Monoclonal Antibodies in Breast and Gynec Cancer Patients. J Complement Med Res. 2021; 12(4): 148-163. doi:10.5455/jcmr.2021.12.04.24


Vancouver/ICMJE Style

AMIRHOSSEIN SETAYESH, GOPINATH ELUMALAI. The Incidence of Adverse Effects of Monoclonal Antibodies in Breast and Gynec Cancer Patients. J Complement Med Res. (2021), [cited May 26, 2023]; 12(4): 148-163. doi:10.5455/jcmr.2021.12.04.24


Harvard Style

AMIRHOSSEIN SETAYESH, GOPINATH ELUMALAI (2021) The Incidence of Adverse Effects of Monoclonal Antibodies in Breast and Gynec Cancer Patients. J Complement Med Res, 12 (4), 148-163. doi:10.5455/jcmr.2021.12.04.24


Turabian Style

AMIRHOSSEIN SETAYESH, GOPINATH ELUMALAI. 2021. The Incidence of Adverse Effects of Monoclonal Antibodies in Breast and Gynec Cancer Patients. Journal of Complementary Medicine Research, 12 (4), 148-163. doi:10.5455/jcmr.2021.12.04.24


Chicago Style

AMIRHOSSEIN SETAYESH, GOPINATH ELUMALAI. "The Incidence of Adverse Effects of Monoclonal Antibodies in Breast and Gynec Cancer Patients." Journal of Complementary Medicine Research 12 (2021), 148-163. doi:10.5455/jcmr.2021.12.04.24


MLA (The Modern Language Association) Style

AMIRHOSSEIN SETAYESH, GOPINATH ELUMALAI. "The Incidence of Adverse Effects of Monoclonal Antibodies in Breast and Gynec Cancer Patients." Journal of Complementary Medicine Research 12.4 (2021), 148-163. Print. doi:10.5455/jcmr.2021.12.04.24


APA (American Psychological Association) Style

AMIRHOSSEIN SETAYESH, GOPINATH ELUMALAI (2021) The Incidence of Adverse Effects of Monoclonal Antibodies in Breast and Gynec Cancer Patients. Journal of Complementary Medicine Research, 12 (4), 148-163. doi:10.5455/jcmr.2021.12.04.24


Author LoginReviewer LoginAbout PublisherEditorial PoliciesPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information
Copyright © 2023 Journal of Complementary Medicine Research All Rights Reserved. Subject to change without notice from or liability to Journal of Complementary Medicine Research.
For best results, please use Internet Explorer or Google Chrome

Contact Information


Journal of Complementary Medicine Research

Hosted by Ejmanager
C/O Sukasiree Publication,
3990 Hillsboro Pike, Suite 330
Nashville,USA

Email : editorjocmr@gmail.com